Literature DB >> 32858239

Polyvalent Mechanical Bacterial Lysate Administration Improves the Clinical Course of Grass Pollen-Induced Allergic Rhinitis in Children: A Randomized Controlled Trial.

Kamil Janeczek1, Andrzej Emeryk2, Marta Rachel3, Dariusz Duma4, Łukasz Zimmer5, Ewa Poleszak5.   

Abstract

BACKGROUND: Recent studies highlight the immunoregulatory potential of bacterial lysates, indicating their potential use in the prevention and treatment of allergic diseases.
OBJECTIVE: To investigate the clinical efficacy of polyvalent mechanical bacterial lysates (PMBLs) in children with grass pollen-induced allergic rhinitis.
METHODS: Seventy children with seasonal allergic rhinitis were enrolled to this study and were randomly assigned to the PMBL and placebo groups. Severity of seasonal allergic rhinitis symptoms was assessed by the total nasal symptom score, total ocular symptom score, and visual analogue scale. During 3 visits, peak nasal inspiratory flow was measured, and nasal smears for the presence of eosinophils and nasal lavage fluids for the presence of allergen-specific IgE against timothy grass pollen allergens were sampled.
RESULTS: A statistically significant decrease in total nasal symptom score (P = .001), total ocular symptom score (P = .04), and visual analogue scale score for nasal and eye symptoms (P < .001 and P < .001, respectively) and an increase in peak nasal inspiratory flow (P = .04) were observed in the PMBL group versus the placebo group. During the grass pollen season, an increase and then a decrease in the number of eosinophils in nasal smears was observed in both groups; however, the number of eosinophils was significantly lower in the PMBL group versus the placebo group. No significant changes in allergen-specific IgE concentrations were observed in the PMBL group, whereas in the placebo group a statistically significant increase in allergen-specific IgE concentration was observed.
CONCLUSIONS: Sublingual administration of PMBLs during the grass pollen season offers significant efficacy in alleviating seasonal allergic rhinitis symptoms in children sensitized to grass pollen allergens. PMBLs probably affect mucosal immunity, weakening the response of TH2 cells.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergic rhinitis; Bacterial lysate; Children; Eosinophils; Grass pollen season; PMBL sublingual tablet; Seasonal allergic rhinitis; Specific IgE; T(H)2-type inflammation

Year:  2020        PMID: 32858239     DOI: 10.1016/j.jaip.2020.08.025

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  5 in total

1.  A Case-Control Study on the Changes in Natural Killer Cell Activity following Administration of Polyvalent Mechanical Bacterial Lysate in Korean Adults with Recurrent Respiratory Tract Infection.

Authors:  Yun Kyong Lee; Ji-Hee Haam; Eunkyung Suh; Sung Hoon Cho; Young-Sang Kim
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

2.  Nasal carriage of Staphylococcus aureus in children with grass pollen-induced allergic rhinitis and the effect of polyvalent mechanical bacterial lysate immunostimulation on carriage status: A randomized controlled trial.

Authors:  Kamil Janeczek; Andrzej Emeryk; Łukasz Zimmer; Ewa Poleszak; Michał Ordak
Journal:  Immun Inflamm Dis       Date:  2021-12-29

Review 3.  Perspectives for the Use of Bacterial Lysates for the Treatment of Allergic Rhinitis: A Systematic Review.

Authors:  Kamil Janeczek; Agnieszka Kaczyńska; Andrzej Emeryk; Cemal Cingi
Journal:  J Asthma Allergy       Date:  2022-06-23

Review 4.  Promising Immunomodulatory Effects of Bacterial Lysates in Allergic Diseases.

Authors:  Agnieszka Kaczynska; Martyna Klosinska; Kamil Janeczek; Michał Zarobkiewicz; Andrzej Emeryk
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

5.  Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.

Authors:  Geertje M de Boer; Gert-Jan Braunstahl; Esmee K van der Ploeg; Cathelijne M van Zelst; Alie van Bruggen; Guido Epping; Menno van Nimwegen; Gert Verhoeven; Erwin Birnie; Bianca M Boxma-de Klerk; Marjolein J W de Bruijn; Ralph Stadhouders; Rudi W Hendriks; Gerdien A Tramper-Stranders
Journal:  Clin Exp Allergy       Date:  2021-08-06       Impact factor: 5.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.